Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Developing a Methodology to Assess 8-aminoquinoline Associated Haemolytic Risk in Females Heterozygous for G6PD in Endemic Populations

NCT03337152 is registered in ClinicalTrials.gov with PATH as lead sponsor.

NCT NCT03337152
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03337152 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Developing a Methodology to Assess 8-aminoquinoline Associated Haemolytic Risk in Females Heterozygous for G6PD in Endemic Populations
Lead sponsor
PATH
Phase
Phase 4
Overall status
Terminated
Start date
May 7, 2018
Completion date
October 21, 2018
Enrollment
54 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

g6pd deficiency, malaria, vivax